Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?
Massy
Z A
ZA
Department of Medicine, Hennepin County Medical Center, South, Minneapolis, MN 55415, USA.
Keane
W F
WF
Kasiske
B L
BL
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000494:pharmacology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D066298:In Vitro Techniques; D008798:Mevalonic Acid / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D008798:Mevalonic Acid